IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$307M
AUM Growth
-$43.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1 +$14M
2 +$9.92M
3 +$8.62M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.53M
5
PCVX icon
Vaxcyte
PCVX
+$7.55M

Top Sells

1 +$6.57M
2 +$6.3M
3 +$6.17M
4
BPMC
Blueprint Medicines
BPMC
+$4.91M
5
BBIO icon
BridgeBio Pharma
BBIO
+$4.32M

Sector Composition

1 Healthcare 95.44%
2 Consumer Staples 0%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKT icon
51
Rocket Pharmaceuticals
RCKT
$400M
$1.48M 0.18%
221,911
VTYX icon
52
Ventyx Biosciences
VTYX
$280M
$1.4M 0.17%
1,217,590
+125,000
RCUS icon
53
Arcus Biosciences
RCUS
$1.75B
$1.28M 0.16%
163,363
-215,000
DCTH icon
54
Delcath Systems
DCTH
$419M
$1.28M 0.16%
100,365
SGMO icon
55
Sangamo Therapeutics
SGMO
$193M
$1.22M 0.15%
1,860,179
VKTX icon
56
Viking Therapeutics
VKTX
$3.77B
$1.21M 0.15%
+50,000
TDOC icon
57
Teladoc Health
TDOC
$1.51B
$1.19M 0.15%
+150,000
ALEC icon
58
Alector
ALEC
$308M
$1.17M 0.14%
950,000
OKUR
59
OnKure Therapeutics
OKUR
$37.6M
$1.09M 0.13%
253,754
NUVB icon
60
Nuvation Bio
NUVB
$1.17B
$1.09M 0.13%
619,258
+535,851
NKTR icon
61
Nektar Therapeutics
NKTR
$1.1B
$1.07M 0.13%
105,302
-29,967
TRML icon
62
Tourmaline Bio
TRML
$1.23B
$1.03M 0.13%
67,927
IMUX icon
63
Immunic
IMUX
$79M
$996K 0.12%
914,170
-700,000
TERN icon
64
Terns Pharmaceuticals
TERN
$736M
$851K 0.1%
308,491
SLDB icon
65
Solid Biosciences
SLDB
$458M
$851K 0.1%
+230,000
ETNB icon
66
89bio
ETNB
$2.19B
$727K 0.09%
+100,000
OLMA icon
67
Olema Pharmaceuticals
OLMA
$642M
$722K 0.09%
191,994
+100,000
VERU icon
68
Veru
VERU
$60.2M
$699K 0.09%
142,524
+48,000
LXRX icon
69
Lexicon Pharmaceuticals
LXRX
$516M
$653K 0.08%
1,417,952
-132,048
GLUE icon
70
Monte Rosa Therapeutics
GLUE
$621M
$634K 0.08%
136,575
-175,000
PTHS
71
Pelthos Therapeutics
PTHS
$89M
$626K 0.08%
+44,085
PYXS icon
72
Pyxis Oncology
PYXS
$208M
$601K 0.07%
613,253
INBX icon
73
Inhibrx
INBX
$540M
$589K 0.07%
42,122
FULC icon
74
Fulcrum Therapeutics
FULC
$486M
$576K 0.07%
200,096
SWTX
75
DELISTED
SpringWorks Therapeutics
SWTX
$552K 0.07%
12,519
-25,000